Parnax Lab Ltd manufactures and exports Pharmaceutical FormulationsBusiness Overview: PLL is a part Naxpar Group and is a WHO-approved and EHS-compliant Company. It is into contract manufacturing of Liquid Orals, Capsules, Ointments, External Powders & Tablets with its manufacturing facility located at Silvassa.
Parnax Lab has announced the outcomes of its recent board meeting. The company approved the financial results for the quarter ended June 30, 2025. Standalone revenue from operations was ₹1.97 Cr, with a profit of ₹0.23 Cr. Consolidated revenue stood at ₹53.38 Cr, and consolidated profit after tax was ₹3.27...
Parnax Lab Ltd. has announced that no dematerialization requests were received during the quarter ended June 30, 2025, as confirmed by its Registrar and Transfer Agent, MUFG Intime India Pvt. Ltd. The company confirmed that any securities received for dematerialization during this period were processed and listed appropriately, with the...
Parnax Lab Limited has announced a secretarial compliance report for the financial year ended March 31, 2025, certified by HSPN & Associates LLP. The report confirms that the company adhered to all applicable statutory provisions and maintained robust board processes and compliance mechanisms. There were no deviations or penalties during...
Parnax Lab Limited has announced a board meeting to discuss the financial results for the quarter and half-year. The company received confirmation from its Registrar & Transfer Agents indicating there were no dematerialization requests during the quarter ended 31 March 2025. This stability may reflect operational consistency and could be...
